94 related articles for article (PubMed ID: 8604004)
21. Induction of urokinase-type plasminogen activator by lipopolysaccharide in PC-3 human prostatic cancer cells.
Ohta S; Niiya K; Sakuragawa N; Fuse H
Thromb Res; 2000 Mar; 97(5):343-7. PubMed ID: 10709910
[TBL] [Abstract][Full Text] [Related]
22. Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria.
Isaksson GL; Hinrichs GR; Andersen H; Bach ML; Weyer K; Zachar R; Henriksen JE; Madsen K; Lund IK; Mollet G; Bistrup C; Birn H; Jensen BL; Palarasah Y
J Am Soc Nephrol; 2024 Apr; 35(4):410-425. PubMed ID: 38254266
[TBL] [Abstract][Full Text] [Related]
23. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
24. Monocyte urokinase expression: modulation by interleukins.
Gyetko MR; Wilkinson CC; Sitrin RG
J Leukoc Biol; 1993 May; 53(5):598-601. PubMed ID: 8501398
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
[TBL] [Abstract][Full Text] [Related]
26. Urokinase plasminogen activator mRNA is induced by IL-1alpha and TNF-alpha in in vitro acantholysis.
Feliciani C; Toto P; Wang B; Sauder DN; Amerio P; Tulli A
Exp Dermatol; 2003 Aug; 12(4):466-71. PubMed ID: 12930304
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
Niedbala MJ; Stein M
Biomed Biochim Acta; 1991; 50(4-6):427-36. PubMed ID: 1801706
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.
Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225
[TBL] [Abstract][Full Text] [Related]
29. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
Wells JM; Strickland S
J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
[TBL] [Abstract][Full Text] [Related]
30. Plasmin modulators, aprotinin and anti-catalytic plasmin antibody, efficiently inhibit destruction of bovine vascular endothelial cells by choriocarcinoma cells.
Sugimura M; Kobayashi H; Terao T
Gynecol Oncol; 1994 Mar; 52(3):337-46. PubMed ID: 7512520
[TBL] [Abstract][Full Text] [Related]
31. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
[TBL] [Abstract][Full Text] [Related]
32. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.
Hearing VJ; Law LW; Corti A; Appella E; Blasi F
Cancer Res; 1988 Mar; 48(5):1270-8. PubMed ID: 2963689
[TBL] [Abstract][Full Text] [Related]
33. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
Levenson AS; Kwaan HC; Svoboda KM; Weiss IM; Sakurai S; Jordan VC
Br J Cancer; 1998 Jul; 78(1):88-95. PubMed ID: 9662256
[TBL] [Abstract][Full Text] [Related]
34. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
Cubellis MV; Andreasen P; Ragno P; Mayer M; Danø K; Blasi F
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4828-32. PubMed ID: 2544876
[TBL] [Abstract][Full Text] [Related]
35. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
36. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
Stillfried GE; Saunders DN; Ranson M
Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
[TBL] [Abstract][Full Text] [Related]
38. LPS induced procoagulant activity and plasminogen activator activity in mononuclear cells from persons with high or low levels of HDL lipoprotein.
Eggesbø JB; Hjermann I; Ovstebø R; Joø GB; Kierulf P
Thromb Res; 1995 Mar; 77(5):441-52. PubMed ID: 7778059
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.
Zhang Y; Doerfler M; Lee TC; Guillemin B; Rom WN
J Clin Invest; 1993 May; 91(5):2076-83. PubMed ID: 7683696
[TBL] [Abstract][Full Text] [Related]
40. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines.
Nusrat AR; Chapman HA
J Clin Invest; 1991 Mar; 87(3):1091-7. PubMed ID: 1847936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
